Abstract
A young female patient presented as an acute medical emergency with hypoglycaemia. Investigations revealed panhypopituitarism and an inflammatory pituitary mass. An antibody screen was negative for anti-neutrophil cytoplasmic antibodies with cytoplasmic distribution (cANCA). Pituitary histology showed lymphocytic infiltration and a few Langerhan’s cells. The pituitary mass rapidly expanded to involve the optic nerves and led to bilateral blindness. Later, the patient developed diarrhoea, a vasculitis rash, scleritis, and proteinuria. In subsequent investigations cANCA became positive. The patient responded to steroids and cyclophosphamide treatment and remained in partial remission for six months before dying of severe sepsis. This is the first description of Wegener’s granulomatosis presenting with acute anterior pituitary failure in the absence of other organ involvement and negative serology.
Avoid common mistakes on your manuscript.
Introduction
A heterogeneous group of diseases can present as an inflammatory mass in the pituitary fossa [1]. These diseases are either primary (intrinsic to the pituitary, aetiology unknown) or secondary (an etiologic agent or systemic disease is implicated). The clinical presentation of such lesions is often similar to pituitary adenomas, although headache, nausea and vomiting and posterior pituitary involvement are more common presentations of hypophysitis than pituitary adenomas [1]. Infection is a rare cause of hypophysitis but should be considered in the differential diagnosis of hypophysitis [2]. If suspected pre-operatively, full clinical and laboratory assessment of patients may provide the definitive diagnosis allowing the institution of appropriate medical therapy. However in the absence of a definitive clinical diagnosis at the time of presentation, surgery and histological diagnosis is essential to reach the ultimate diagnosis.
Case report
A 22-year-old female was admitted to hospital as an emergency following a collapse five weeks before referral to our centre. She was hypothermic, hypoglycaemic and hypotensive with no axillary and scanty pubic hair. Investigations confirmed the clinical suspicion of an acute pituitary insufficiency (Table 1). She was resuscitated and subsequently stabilised on hydrocortisone, thyroxine, and oestrogen replacement therapy. An MRI revealed a heterogeneous enhancing pituitary mass and thickened mucosa of the sphenoid sinus (Fig. 1). On review of her past medical history her menarche was at 11 years. She developed secondary amenorrhoea at the age of 14. At 17 years of age her serum gonadotrophins, oestradiol and prolactin concentrations were measured and found to be low as part of a gynaecological assessment for her amenorrhoea. No further investigations were undertaken at that time. Throughout her teenage years, she had recurrent headaches diagnosed as migraine. She denied symptomatic sinusitis, chronic rhinitis or epistaxis. For six months prior to her collapse she had been generally unwell with increasing frequency and severity of headaches. A month before her admission she had an episode of confusion lasting for 30 min.
Five weeks after her presentation with collapse, she continued to have headaches. She was referred to our centre for further assessment. Auto-antibody titres including anti-nuclear cytoplasmic antibodies (ANCA), serum angiotensin converting enzyme (ACE), a chest X-ray and urine microscopy were normal. She underwent trans-sphenoidal surgery six weeks after her initial presentation with collapse. At surgery a firm mass of fibrous tissue was found occupying the pituitary fossa. Excision of the pituitary mass was impossible but biopsies were taken. Histology showed a dense fibrous infiltrate with a few nests of non-specific chronic inflammatory cells. On the second post-operative day she developed a partial right third nerve palsy. Repeat MRI scan revealed expansion of the tissue mass into the right cavernous sinus. Despite high doses of dexamethasone the partial third nerve palsy persisted, although the headache improved. She awoke on the sixth post-operative day with bilateral blindness and fixed dilated pupils. She underwent emergency transfrontal craniotomy. Both optic nerves and the optic chiasm were infiltrated by a dense waxy fibrous mass extending from the pituitary fossa. Biopsies were taken. Histology showed a chronic inflammatory process and Langerhan’s cells were identified. A working diagnosis of Langerhan’s cell histiocytosis was reached. External beam radiotherapy to the pituitary was commenced three months after her initial presentation with collapse. The radiotherapy was discontinued after nine fractions when further information from immuno-histochemistry of the inflammatory pituitary mass from her second operation showed a necrotizing infiltrative inflammatory reaction with no staining for S100 or CD1a. Meantime culture and PCR analysis of the pituitary tissue for acid fast bacilli and serology for parvovirus, mycoplasma, herpes simplex, measles, varicella zoster, rubella, leptospira, brucella and cryptococcus were negative. A new histopathological diagnostic consensus of atypical lymphocytic hypophysitis was reached.
In the subsequent two months the patient remained a difficult management problem with severe headaches, helped little by a spectrum of analgesics including opioid analgesics and high dose oral steroids. Five months after the original presentation with acute pituitary insufficiency, the patient developed polyuria and polydipsia and investigations confirmed cranial diabetes insipidus. She was treated with desmopressin.
Six months after her initial presentation with collapse, repeat MRI scans showed further expansion of the pituitary mass with significant involvement and enhancement of the meninges bilaterally over the frontal lobes (Fig. 2). A week later she developed a vasculitic rash on her limbs, abdominal pain and diarrhoea. Her inflammatory markers, for the first time during her illness became raised (Table 1). Skin biopsy showed inflammation and microabscesses either secondary to septic emboli, or a primary vasculitic process. Cultures of blood, urine, faeces, and skin biopsy specimens were negative, echocardiography was normal as was CT of chest and abdomen. Lumbar puncture was normal. A formal dura biopsy was considered however over the following week she became drowsy, developed recurrent left hemiparesis, sensorineural hearing impairment and necrotizing scleritis of both eyes. Serum cANCA titre (previously negative on several occasions) was positive and proteinase three antibody was also positive (Table 1). Six and a half months after her initial presentation with collapse and acute hypopituitarism a diagnosis of Wegener’s granulomatosis (WG) was made. Examination of the urine showed red cell casts on microscopy, urine culture was negative and serum creatinine remained normal (Table 1).
The patient commenced on intravenous high dose methyl-prednisolone and cyclophosphamide therapy. After three pulsed doses of immunosuppressive therapy the vasculitic rash and diarrhoea resolved, serum ANCA titres fell to 1 in 20 and the patient’s higher cerebral function improved dramatically, however she remained blind with some hearing impairment. In the following six months she achieved a stable partial remission, maintained with cyclophosphamide and steroids, however the patient then presented with overwhelming sepsis and died 13 months after her initial presentation.
Discussion
Histology in our patient showed a mixed chronic inflammatory cell infiltrate, no caseous necrosis was seen and PCR and cultures were negative for TB. Sarcoidosis was considered unlikely as there was no systemic manifestation of this disease and serum ACE levels were negative. The cell infiltrate was not monoclonal excluding conditions such as lymphoma. Initial histology showed sheets of histiocytes possibly supporting the diagnosis of Langerhan’s histiocytosis. The absence of immunohistochemical staining for S100 protein led to the rejection of this diagnosis [3]. The spectrum of disorders associated with inflammatory hypophysitis is broad and includes lymphocytic hypophysitis, granulomatous hypophysitis, xanthomatous hypophysitis [1, 2]. Lymphocytic hypophysitis usually presents in young women and may present in late pregnancy or in the early post-partum period [2]. An association with autoimmune conditions, particularly type 1 diabetes has been described and the histology typically shows lymphocytic infiltration forming follicles. The pathogenesis is probably autoimmune [4, 5]. The presentation of lymphocytic hypophysitis is commonly with hypopituitarism, the effects of an expanding pituitary mass (appearing as a solid mass on pituitary imaging), hyperprolactinaemia and less frequently posterior pituitary disturbance. Granulomatous hypophysitis, is rare and comprises less than 1% of all pituitary disorders with an incidence of 1 in 10 million per annum [2, 6]. It affects both sexes equally with a peak incidence in the second decade of life for women and fifth decade for men. Common presenting features are nausea, vomiting, meningitis, hyperprolactinaemia and diabetes insipidus. The radiological appearances are non-specific and consist of pituitary mass, which may be have both cystic and solid components and may extend beyond the sella [2, 7]. Histological characteristics include histiocytes, multinucleated giant cells and other inflammatory cells. Xanthomatous hypophysitis is very rare and characterised by the presence of foamy histiocytes [2, 8]. Occasionally hypophysitis may be associated with ruptured Rathke’s cleft cyst [9], Takayasu’s disease [10] or Crohn’s disease [11].
Our patient had atypical histology. There was only one giant cell granuloma identified hence a diagnosis of granulomatous hypophysitis could not be reached. It was relatively late in the natural history of the disease process, when a definitive diagnosis of WG could be made based on clinical and serological criteria.
WG is a systemic small vessel vasculitis, which mainly affects sinuses, lungs and kidneys [12] but can affect several other organs including the central nervous system [13] and rarely the pituitary [14–18]. Granulomas are rare in WG involving head and neck [19]. The prevalence of ANCA in the serum of WG patients at some time in the course of their disease is 85–90% [20]. About 90% of patients with active untreated systemic WG have proteinase three-specific ANCA (PR3-ANCA) [21].
A few cases have been previously reported in which pituitary dysfunction was the first manifestation of WG, in all of these cases patients presented with diabetes insipidus [14, 15, 17, 18, 22].
Our patient was unusual in that she presented with acute anterior pituitary failure in the absence of involvement of any other organs by WG, while inflammatory markers were not raised and cANCA was undetectable. Our patient only developed weakly positive titres when her disease was multi-system and advanced. In retrospect the history of secondary amenorrhoea associated with biochemical evidence of gonadotrophin deficiency and headaches, suggest that the onset of WG may have been five years earlier.
MRI features of intracranial WG have been described in some detail and can be useful diagnostically especially when there is continuity of the lesion with orbital, nasal or paranasal sinuses [6, 23].
In our patient, the diagnosis was delayed because initial MRI and pituitary histology were not diagnostic. The serology turned positive for cANCA only late in the course of disease, at which time the patient had evidence of multi-system involvement. Previous reports illustrate that cANCA may be negative in 25% of localised WG [24]. Titres of cANCA tend to reflect disease activity [24, 25] and hence the seroconversion of our patient was indicative of increased disease activity and development of multi-organ involvement.
This rare presentation of WG posed significant diagnostic and management dilemmas to the physicians and surgeons involved and highlights several key learning points: (a) WG can rarely present with pituitary failure; (b) localised WG may not be associated with positive ANCA titres to aid diagnosis; (c) pituitary histopathology may not be diagnostic of the disease process, and therefore clinical suspicion is important; (d) in patients presenting with atypical pituitary lesions, especially when headache is a dominant symptom [26, 27] or if cranial nerve involvement is also present, WG should be considered in the differential diagnosis. cANCA should be measured repeatedly when the nature of a pituitary inflammatory mass remains unclear.
References
Sam S, Molitch ME (2005) The pituitary mass: diagnosis and management. Rev Endocr Metab Disord 6:55–62
Cheung CC, Ezzat S, Smyth HS, Asa SL (2001) The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab 86:1048–1053
Rodriguez-Pereira C, Borras-Moreno JM, Pesudo-Martinez JV, Vera-Roman JM (2005) Cerebral solitary Langerhans cell histiocytosis: report of two cases and review of the literature. Br J Neurosurg 19:192–197
Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614
Laws ER, Vance ML, Jane JA Jr (2006) Hypophysitis. Pituitary 9:331–333
Sautner D, Saeger W, Lüdecke DK, Jansen V, Puchner MJA (1995) Hypophysitis in surgical and autoptical specimens. Acta Neuropathol (Berl) 90:637–644
Lury KM (2005) Inflammatory and infectious processes involving the pituitary gland. Top Magn Reson Imaging 16:301–306
Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK (2003) Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 6:161–168
Roncaroli F, Bacci A, Frank G, Calbucci F (1998) Granulomatous hypophysitis caused by a ruptured intrasellar Rathke’s cleft cyst: report of a case and review of the literature. Neurosurgery 43:146–149
Toth M, Szabo P, Racz K, Szende B, Balogh I, Czirjak S, Slowik F, Glaz E (1996) Granulomatous hypophysitis associated with Takayasu’s disease. Clin Endocrinol 45:499–503
de Bruin WI, van’t Verlaat JW, Graamans K, de Bruin TW (1991) Sellar granulomatous mass in a pregnant woman with active Crohn’s disease. Neth J Med 39:136–141
Slot MC, Tervaert JW (2004) Wegener’s granulomatosis. Autoimmunity 37:313–315
Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 85:54–65
Miesen WM, Janssens EN, van Bommel EF (1999) Diabetes insipidus as the presenting symptom of Wegener’s granulomatosis. Nephrol Dialys Transplant 14:426–429
Tappouni R, Burns A (2000) Pituitary involvement in Wegener’s granulomatosis. Nephrol Dialys Transplant 15:2057–2058
Goyal M, Kucharczyk W, Keystone E (2000) Granulomatous hypophysitis due to Wegener’s granulomatosis. Am J Neuroradiol 21:1466–1469
Garovic VD, Clarke BL, Chilson TS, Specks U (2001) Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener’s granulomatosis. Am J Kidn Dis 37:E5
Duzgun N, Morris Y, Gullu S, Gursoy A, Ensari A, Kumbasar OO, Duman M (2005) Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener’s granulomatosis. Rheumatol Internat 26:80–82
Batsakis JG, Luna MA (1987) Midfacial necrotizing lesions. Semin Diagn Pathol 4:90–116
Stone JH (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthr Rheumat 48:2299–2309
Bosch X, Guilabert A, Font J (2006) Antineutrophil cytoplasmic antibodies. Lancet 368:404–418
Haynes BF, Fauci AS (1978) Diabetes insipidus associated with Wegener’s granulomatosis successfully treated with cyclophosphamide. N Engl J Med 299:764
Murphy JM, Gomez-Anson B, Gillard JH, Antoun NM, Cross J, Elliot JD, Lockwood M (1999) Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology 213:794–799
Kallenberg CGM, Mulder AHL, Tervaert JWC (1992) Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 93:675–681
George J, Levy Y, Kallenberg CGM, Schoenfeld Y (1997) Infections and Wegener’s granulomatosis-a cause and effect relationship? Q J Med 90:367–373
Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ (1999) Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am J Neuroradiol 20:519–23
Goyal M, Kucharczyk W, Keystone E (2000) Granulomatous hypophysitis due to Wegener’s granulomatosis. AJNR Am J Neuroradiol 21:1466–1499
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McIntyre, E.A., Perros, P. Fatal inflammatory hypophysitis. Pituitary 10, 107–111 (2007). https://doi.org/10.1007/s11102-007-0016-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-007-0016-z